(1R,3s,5S)-8-Benzyl-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane

We are (1R,3s,5S)-8-Benzyl-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane CAS:423165-13-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Product Name:
(1R,3s,5S)-8-Benzyl-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane
Synonym: 8-Benzyl-3-exo-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane; Intermediate of Maraviroc
Cas No.: 423165-13-3
Formula: C₂₀H₂₈N₄
MW: 324.46
EINECS No.: 1533716-785-6

HS Code: 2933990099

UN No.: N.A
Hazard class: Non-dangerous goods
 
Specification

Items of Analysis	Standard of Analysis	Test Results
Appearance	White or similar white powder	Conforms
Purity (HPLC)	≥99%	99.75%
Single Impurity	≤1.0%	0.07%
Total impurities	≤1.0%	0.25%
Loss on drying	≤0.5%	0.12%
Residue on Ignition	≤0.15%	0.13%
Conclusion	Conforms to Factory Standard

 
 
Application
Intermediate of Maraviroc.
 
Packaging
25 kg/barrel, can also be packaged according to customer requirements. 
 
Storage
Store in a cool, ventilated warehouse. 
Keep away from fire and heat. 
The temperature should not exceed 37 °C. 




Related News: The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.1003709-96-3 The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.2- (1-imidazolil) acetato de etilo CAS:17450-34-9 It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.2455-24-5 The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.